Filter by: patients
Home > Community Treatment Reports and Side Effects > Istradefylline Treatment Report
What is Istradefylline?

Istradefylline is an experimental treatment for Parkinson's disease, intended to reduce the duration of "off" periods. Read more...Click to read more below

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Parkinson's Disease 2 0

See 1 patient currently taking Istradefylline

Mouse over the table for more information

Reported Dosages

  40 mg daily
  1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Istradefylline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 1   Course of treatment ended: 100%

See all 1 patient who’ve stopped taking Istradefylline

Reported Duration See details about how long patients take this treatment ▼

Stopped Taking Istradefylline

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Report created on February 11, 2012.